Smart-Money SignalNeutral · 45/100— Insiders are net sellers over 90 days (-$142K, 3 sales vs 4 buys)
Revenue$21.1M
Net Income$127.1M
EPS$0.33
Gross Margin53.5%
Market Cap$352.0M
Price Performance
Historical data including institutional events
Company Profile
M
Michael Egholm
CEO & Executive Director
Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.
